15-89333596-TTGCTGCTGCTGCTGCTGCTGCTGCTGCTGC-TTGCTGCTGCTGCTGCTGCTGCTGCTGC

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP3BP6_Very_StrongBS2

The NM_001430120.1(POLGARF):​c.211_213delGCA​(p.Ala71del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0109 in 1,579,960 control chromosomes in the GnomAD database, including 92 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0090 ( 5 hom., cov: 30)
Exomes 𝑓: 0.011 ( 87 hom. )

Consequence

POLGARF
NM_001430120.1 conservative_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 0.0750
Variant links:
Genes affected
POLGARF (HGNC:56246): (POLG alternative reading frame) This gene uses the same transcript as the POLG gene but has a CUG start codon and an alternate reading frame that makes a 260 aa protein. This protein is distinct from POLG isoforms and may interact with P32 (also known as C1QBP), a mitochondrial matrix protein thought to be involved in the expression of mitochondrial genome-encoded proteins. POLGARF protein may bind P32 and sequester it in the nucleolus. Interestingly, some disease-causing mutations thought to be in POLG may instead be associated with POLGARF. [provided by RefSeq, May 2022]
POLG (HGNC:9179): (DNA polymerase gamma, catalytic subunit) Mitochondrial DNA polymerase is heterotrimeric, consisting of a homodimer of accessory subunits plus a catalytic subunit. The protein encoded by this gene is the catalytic subunit of mitochondrial DNA polymerase. The encoded protein contains a polyglutamine tract near its N-terminus that may be polymorphic. Defects in this gene are a cause of progressive external ophthalmoplegia with mitochondrial DNA deletions 1 (PEOA1), sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO), Alpers-Huttenlocher syndrome (AHS), and mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE). Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001430120.1
BP6
Variant 15-89333596-TTGC-T is Benign according to our data. Variant chr15-89333596-TTGC-T is described in ClinVar as [Likely_benign]. Clinvar id is 167521.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-89333596-TTGC-T is described in Lovd as [Benign]. Variant chr15-89333596-TTGC-T is described in Lovd as [Benign].
BS2
High Homozygotes in GnomAd4 at 5 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POLGNM_002693.3 linkc.156_158delGCA p.Gln53del disruptive_inframe_deletion Exon 2 of 23 ENST00000268124.11 NP_002684.1 P54098E5KNU5
POLGARFNM_001430120.1 linkc.211_213delGCA p.Ala71del conservative_inframe_deletion Exon 1 of 2 NP_001417049.1
POLGNM_001126131.2 linkc.156_158delGCA p.Gln53del disruptive_inframe_deletion Exon 2 of 23 NP_001119603.1 P54098E5KNU5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POLGARFENST00000706918.1 linkc.211_213delGCA p.Ala71del conservative_inframe_deletion Exon 1 of 2 ENSP00000516626.1 A0A3B3IS91
POLGENST00000268124.11 linkc.156_158delGCA p.Gln53del disruptive_inframe_deletion Exon 2 of 23 1 NM_002693.3 ENSP00000268124.5 P54098

Frequencies

GnomAD3 genomes
AF:
0.00902
AC:
1367
AN:
151586
Hom.:
5
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00410
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00957
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.000966
Gnomad SAS
AF:
0.00729
Gnomad FIN
AF:
0.0245
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0107
Gnomad OTH
AF:
0.00771
GnomAD4 exome
AF:
0.0111
AC:
15824
AN:
1428270
Hom.:
87
AF XY:
0.0110
AC XY:
7817
AN XY:
709892
show subpopulations
Gnomad4 AFR exome
AF:
0.00431
Gnomad4 AMR exome
AF:
0.00861
Gnomad4 ASJ exome
AF:
0.00599
Gnomad4 EAS exome
AF:
0.00320
Gnomad4 SAS exome
AF:
0.00935
Gnomad4 FIN exome
AF:
0.0275
Gnomad4 NFE exome
AF:
0.0113
Gnomad4 OTH exome
AF:
0.0101
GnomAD4 genome
AF:
0.00902
AC:
1369
AN:
151690
Hom.:
5
Cov.:
30
AF XY:
0.00933
AC XY:
692
AN XY:
74152
show subpopulations
Gnomad4 AFR
AF:
0.00414
Gnomad4 AMR
AF:
0.00956
Gnomad4 ASJ
AF:
0.00317
Gnomad4 EAS
AF:
0.000969
Gnomad4 SAS
AF:
0.00730
Gnomad4 FIN
AF:
0.0245
Gnomad4 NFE
AF:
0.0107
Gnomad4 OTH
AF:
0.00763

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mar 12, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Aug 04, 2016
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jun 12, 2014
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The variant is found in EPILEPSY,CHILD-EPI,MITONUC-MITOP panel(s). -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:3
Oct 26, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 27, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

POLG: BS1, BS2 -

Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1 Benign:1
Oct 06, 2023
Molecular Genetics, Royal Melbourne Hospital
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Jul 07, 2016
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Hereditary spastic paraplegia Benign:1
Nov 10, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

POLG-related disorder Benign:1
Mar 27, 2020
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Progressive sclerosing poliodystrophy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41550117; hg19: chr15-89876827; API